II. Indications
- FDA approved Conditions
- Active Tuberculosis
- As part of multi-drug regimen
- Neisseria Meningitidis Carrier
- Active Tuberculosis
- Off-Label Conditions
III. Contraindications
- Multiple Drug Interactions (especially lowering the serum levels of HIV Medications)
- Use only with caution with HIV Medications
IV. Mechanism
- Semisynthetic Rifamycin derivative active against Mycobacteria
- Rifamycin is produced by Streptomyces mediterranei
- Rifamycins inhibit Bacterial DNA-dependent RNA Polymerase, blocking Bacterial RNA formation and transcription
- Drug resistance emerges rapidly
- Must be used with other antituberculous drugs
V. Dosing
-
General
- No Renal Dosing adjustment needed
- Take oral doses on an empty Stomach
-
Active Tuberculosis (as part of multi-drug regimen)
- Adult: 10 mg/kg/day (up to 600 mg) oral or IV daily
- Child: 10 to 20 mg/kg/day (up to 600 mg) oral or IV daily
-
Neisseria Meningitidis Carrier
- Adult: 600 mg orally twice daily for 2 days
- Child: 10 mg/kg/day (up to 600 mg) orally twice daily for 2 days
- Use 5 mg/kg orally twice daily for 2 days IF age <1 month
VI. Adverse Effects: General
- Drug-Induced Hepatitis (see hepatotoxicity risks below)
- Hyperbilirubinemia (transient)
- Nephritis or Acute Renal Failure
- Pruritus with or without Rash
- Thrombocytopenia
- Hemolytic Anemia
-
Influenza-like Syndrome
- Associated with infrequent dosing
- Immune Reconstitution Inflammatory Syndrome (HIV patients)
- False Positive on drug screening for Opiates
- Body fluids become orange-brown tinged
- Urine
- Sweat
- Dentures
- Tears (may discolor Contact Lenses)
VII. Adverse Effects: Hepatotoxicity - Risk Factors
- Slow acetylators
- Hepatitis C
- Hepatitis B
- Concurrent Hepatotoxin exposure
- Age over 50 years
- Pregnancy and postpartum (within 3 months)
- Malnutrition
- HIV Infection
- Alcoholism
VIII. Safety
- Considered safe in Lactation
- Pregnancy
- Benefit typically outweighs risk
- Risk of Hemorrhagic Diathesis of the Newborn (Neonatal Vitamin K Deficiency)
- Give Vitamin K 10 mg IM to newborns
IX. Drug Interactions
- Background
- Strong CYP450 enzyme inducer
- Increases other drug elimination, decreased levels and decreased efficacy
-
Warfarin (Coumadin)
- Obtain INR weekly until stable and then for at least one month after stopping Rifampin
- Warfarin dose may need to increase up to 5x while on Rifampin
- (2014) Presc lett 21(8): 47
- Phenytoin (Dilantin)
-
Oral Contraceptives (as well as Contraceptive Patch, Estrogen Ring)
- Consider alternative contraceptives (e.g. Depo Provera, IUD)
- Use barrier Contraception with Oral Contraceptives
- Ketoconazole
- Chloramphenicol
- Methadone
-
Antiretroviral therapy (HIV)
- Protease Inhibitors (reduced drug level and efficacy)
- Nonnucleoside reverse transcriptase inhibitors (reduced drug level and efficacy)
X. Monitoring
- Complete Blood Count with Platelets
- Baseline Liver Function Tests
- Periodic LFT testing
- Liver Function Tests repeated 1-2 times monthly if risks for hepatotoxicity
- Stop if LFTs >3x baseline if sympomatic (>5x baseline if asymptomatic)
- Indications for Liver Function Test monitoring as above (see hepatotoxicity risks)
- Follow labs if abnormal or Active Tuberculosis develops
XI. Resources
- Rifampin Capsule (DailyMed)
XII. References
- (2019) Presc Lett, Resource #350309, Tuberculosis Treatment in Adults: FAQ
- (2012) Med Lett Drugs Ther 10(116): 29-36
- (2000) MMWR Recomm Rep 49(RR-6): 1-51 [PubMed]
- Hartman-Adams (2014) Am Fam Physician 89(11): 889-96 [PubMed]
Images: Related links to external sites (from Bing)
Related Studies
rifampin (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
RIFAMPIN 150 MG CAPSULE | Generic | $0.83 each |
RIFAMPIN 300 MG CAPSULE | Generic | $0.73 each |